05 Dec 2022 Research

John Goldman Fellowships for 2023 now open

Leukaemia UK is delighted to announce that we are funding more ground-breaking research in 2023, by continuing our investment in early career scientists and clinicians for our prestigious John Goldman Fellowships.

Applications for the annual fellowship programme are now open to scientists and clinician-scientists working in UK universities, research institutions or hospitals. There is no age limit, although the fellowship programme is designed to provide funding at a critical point in a researcher’s career – the transition to becoming an independent researcher.

The maximum award available is £150,000, for a minimum 18-month and maximum 2-year period.

The John Goldman Fellowships were created in honour of Professor John Goldman (1938 – 2013), a renowned haematologist and pioneer in the treatment of leukaemia.

The awards are aimed at early career researchers with a passion for science, and a desire to develop new ideas and translate scientific advances into clinical practice.

Successful applicants will show that they are the potential scientific/clinical leaders of the future. Their proposed research project must be novel with the capacity to make advances in our knowledge of leukaemia and related diseases and the development of new and kinder treatments.

Find out more about the 2022 John Goldman Fellows and their research projects:

Dr Eman Khatib-Massalha, University of Cambridge: The road to new immunotherapy for MPN patients

Dr Mirjana Efremova, Queen Mary University of London: Can we stop B cell lymphoma cells evading treatment?

Dr Simon Richardson, University of Cambridge: In pursuit of new treatment combinations for B-ALL

Dr Victor Llombart, University College London: Let’s find the off switch for leukaemia

Applications for the 2023 fellowships close on 31 January 2023. Find out more about the application process.